Component Te-S Implants With Tylan 29 mg Implant is a Health Canada–registered veterinary drug (DIN 02245745) held by Elanco Canada Limited, containing Tylosin Tartrate. Health Canada lists its status as Marketed (status date 13 Jan 2020). Nexara Health has matched 24 registrations of Tylosin Tartrate across 4 other regulated markets.
Health Canada registration
| DIN | 02245745 |
|---|---|
| Brand name | Component Te-S Implants With Tylan |
| Active ingredient | Tylosin Tartrate |
| Strength | 29 mg |
| Dosage form | Implant |
| Route | Subcutaneous |
| Company | Elanco Canada Limited |
| Status | Marketed — 13 Jan 2020 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Tylosin Tartrate registered in other markets
24 registrations of the same molecule in 4 national registries outside Canada (first 21 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Denmark | Tilsing Vet. | Dopharma Research B.V. | 200.000 IE/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Tylan Vet. | Elanco GmbH | 200 mg/ml | injektionsvæske, opløsning | National | Laegemiddelstyrelsen |
| Denmark | Tylmasin | Huvepharma NV | 200 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Tylovet | Biovet J.S.C. | 200 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Tylucyl | Vetoquinol Scandinavia AB | 200 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Malaysia | INECTIL 20% Injectable solution | Laboratorios Reveex (asia) Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Tylan 200 mg/ml Injection | Elanco Malaysia Sdn Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Vime Tylovet 50 mg/ml Solution for Injection | Vemedim Sdn Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Poland | Biotyl 200 | Biowet Drwalew Sp. z o.o. | 20 g / 100 ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Biotyl 50 | Biowet Drwalew Sp. z o.o. | 5 g / 100 ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Dophatyl-ject | Dopharma Research B.V. | 200000 j.m./ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Pharmasin | Huvepharma NV | 200 mg/ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Pharmasin | Huvepharma NV | 250 000 IU | Granulat doustny | Bezterminowe | URPL RPL |
| Poland | Tilsol | Ceva Salute Animale S.p.A. | 200 g/1000 g | Proszek do sporządzania roztworu doustnego | Bezterminowe | URPL RPL |
| Poland | Tylan G 100 Premix | Elanco GmbH | 100 g/1 kg | Premiks do sporządzania paszy leczniczej | Bezterminowe | URPL RPL |
| Poland | Tylan Soluble Powder | Elanco GmbH | 1000 g/ 1 kg | Proszek do sporządzania roztworu doustnego | 2026-10-10 | URPL RPL |
| United States | tylosin | Shandong Lukang Shelile Pharmaceutical Co.,Ltd | Powder | FDA NDC | ||
| United States | tylosin phosphate | Shandong Lukang Shelile Pharmaceutical Co.,Ltd | Powder | FDA NDC | ||
| United States | Tylosin tartrate | Shandong Lukang Shelile Pharmaceutical Co., Ltd. | Powder | FDA NDC | ||
| United States | Tylosin Tartrate | Ningxia Taiyicin Biotech Co., Ltd. | Powder | FDA NDC | ||
| United States | Tylosin Tartrate | Medisca Inc. | Powder | FDA NDC |
See every manufacturer of Tylosin Tartrate worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Component Te-S Implants With Tylan (DIN 02245745) marketed in Canada?
Yes. Health Canada lists DIN 02245745 as Marketed as of 13 Jan 2020.
Who holds the Canadian licence for this product?
Elanco Canada Limited is the company of record in the Health Canada Drug Product Database.
Is Tylosin Tartrate registered outside Canada?
Yes — Nexara Health has matched 24 registrations in 4 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02245745, status date 2020-01-13; national medicine registries: FDA NDC, Laegemiddelstyrelsen, NPRA, URPL RPL. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02245745, status date 2020-01-13; national medicine registries: FDA NDC, Laegemiddelstyrelsen, NPRA, URPL RPL.
Health Canada Drug Product Database (DPD), DIN 02245745, status date 2020-01-13; national medicine registries: FDA NDC, Laegemiddelstyrelsen, NPRA, URPL RPL. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.